PHG vs. HOLX, GEHC, WST, ICLR, ZBH, CAH, STE, BNTX, ARGX, and WAT
Should you be buying Koninklijke Philips stock or one of its competitors? The main competitors of Koninklijke Philips include Hologic (HOLX), GE HealthCare Technologies (GEHC), West Pharmaceutical Services (WST), ICON Public (ICLR), Zimmer Biomet (ZBH), Cardinal Health (CAH), STERIS (STE), BioNTech (BNTX), argenx (ARGX), and Waters (WAT). These companies are all part of the "medical" sector.
Hologic (NASDAQ:HOLX) and Koninklijke Philips (NYSE:PHG) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, earnings, community ranking, profitability, dividends, analyst recommendations, institutional ownership and media sentiment.
Hologic received 482 more outperform votes than Koninklijke Philips when rated by MarketBeat users. Likewise, 69.76% of users gave Hologic an outperform vote while only 56.75% of users gave Koninklijke Philips an outperform vote.
In the previous week, Hologic had 10 more articles in the media than Koninklijke Philips. MarketBeat recorded 19 mentions for Hologic and 9 mentions for Koninklijke Philips. Hologic's average media sentiment score of 0.77 beat Koninklijke Philips' score of 0.72 indicating that Koninklijke Philips is being referred to more favorably in the news media.
Hologic currently has a consensus price target of $85.60, suggesting a potential upside of 17.20%. Given Koninklijke Philips' stronger consensus rating and higher possible upside, equities analysts clearly believe Hologic is more favorable than Koninklijke Philips.
Hologic has a beta of 1.01, indicating that its stock price is 1% more volatile than the S&P 500. Comparatively, Koninklijke Philips has a beta of 0.75, indicating that its stock price is 25% less volatile than the S&P 500.
94.7% of Hologic shares are owned by institutional investors. Comparatively, 13.7% of Koninklijke Philips shares are owned by institutional investors. 1.8% of Hologic shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Hologic has a net margin of 11.78% compared to Hologic's net margin of -4.41%. Koninklijke Philips' return on equity of 18.91% beat Hologic's return on equity.
Hologic has higher earnings, but lower revenue than Koninklijke Philips. Koninklijke Philips is trading at a lower price-to-earnings ratio than Hologic, indicating that it is currently the more affordable of the two stocks.
Summary
Hologic beats Koninklijke Philips on 16 of the 18 factors compared between the two stocks.
Get Koninklijke Philips News Delivered to You Automatically
Sign up to receive the latest news and ratings for PHG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PHG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Koninklijke Philips Competitors List
Related Companies and Tools
